• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An unusual case of Idelalisib-related pneumonitis with severe respiratory failure.

作者信息

Sousa Domingos, Couto Maria Eduarda, Tavares Alda, Ribeiro Teresa, Muñoz Fabiana Santos, Domingues Nelson, Oliveira Isabel, Mariz Mário

机构信息

Internal Medicine Department Centro Hospitalar e Universitário do Algarve, E.P.E. Portimão Portugal.

Onco-hematology Department Instituto Português de Oncologia do Porto, y F.G., E.P.E. Porto Portugal.

出版信息

EJHaem. 2020 Oct 26;1(2):420-421. doi: 10.1002/jha2.123. eCollection 2020 Nov.

DOI:10.1002/jha2.123
PMID:35845014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175750/
Abstract
摘要

相似文献

1
An unusual case of Idelalisib-related pneumonitis with severe respiratory failure.一例罕见的与idelalisib相关的肺炎伴严重呼吸衰竭病例。
EJHaem. 2020 Oct 26;1(2):420-421. doi: 10.1002/jha2.123. eCollection 2020 Nov.
2
Pulmonary adverse events related to idelalisib therapy: A single centre experience.与idelalisib治疗相关的肺部不良事件：单中心经验
J Chemother. 2018 Sep;30(5):318-322. doi: 10.1080/1120009X.2018.1516184. Epub 2018 Oct 9.
3
Management of adverse events associated with idelalisib treatment: expert panel opinion.idelalisib治疗相关不良事件的管理：专家小组意见
Leuk Lymphoma. 2015;56(10):2779-86. doi: 10.3109/10428194.2015.1022770. Epub 2015 May 19.
4
Idelalisib-Induced Pneumonitis in Chronic Lymphocytic Leukemia.依地那利昔布诱导的慢性淋巴细胞白血病患者肺炎
Cureus. 2024 May 2;16(5):e59541. doi: 10.7759/cureus.59541. eCollection 2024 May.
5
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis.磷脂酰肌醇 3 激酶抑制剂相关的肺炎：系统评价和荟萃分析。
Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):855-863. doi: 10.1080/17512433.2023.2238602. Epub 2023 Jul 25.
6
Identification of Candidate Risk Factor Genes for Human Idelalisib Toxicity Using a Collaborative Cross Approach.利用协作杂交群体方法鉴定人依鲁替尼毒性的候选风险因子基因。
Toxicol Sci. 2019 Dec 1;172(2):265-278. doi: 10.1093/toxsci/kfz199.
7
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential.idelalisib用于治疗惰性非霍奇金淋巴瘤：临床潜力综述
Onco Targets Ther. 2016 May 18;9:2945-53. doi: 10.2147/OTT.S102573. eCollection 2016.
8
Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases.新型吸入式 PI3Kδ 抑制剂的发现：用于呼吸系统疾病的治疗。
J Med Chem. 2018 Nov 8;61(21):9551-9567. doi: 10.1021/acs.jmedchem.8b00873. Epub 2018 Oct 29.
9
The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment.idelalisib在重度肾功能损害受试者中的药代动力学和安全性。
Cancer Chemother Pharmacol. 2015 Dec;76(6):1133-41. doi: 10.1007/s00280-015-2898-1. Epub 2015 Nov 2.
10
Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas.idelalisib治疗惰性B细胞恶性肿瘤：慢性淋巴细胞白血病及小淋巴细胞或滤泡性淋巴瘤
Blood Lymphat Cancer. 2016;6:1-6. doi: 10.2147/BLCTT.S73530. Epub 2016 Mar 15.

本文引用的文献

1
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.伊德拉利昔单抗治疗慢性淋巴细胞白血病和滤泡性淋巴瘤相关不良事件的管理：多学科立场文件。
Hematol Oncol. 2019 Feb;37(1):3-14. doi: 10.1002/hon.2540. Epub 2018 Sep 5.
2
Idelalisib-induced pneumonitis.依地那利昔布诱发的肺炎。
BMJ Case Rep. 2016 Aug 2;2016:bcr2016216343. doi: 10.1136/bcr-2016-216343.
3
Idelalisib-related pneumonitis.依地利斯布相关肺炎
Eur Respir J. 2016 Apr;47(4):1280-3. doi: 10.1183/13993003.01670-2015. Epub 2016 Feb 25.